U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Description

Murodermin (also known as recombinant murine epidermal growth factor), is a recombinant form of mouse epidermal growth factor (EGF) and an EGF receptor agonist which was never marketed.

Originator

Approval Year

Unknown
149124
PubMed

PubMed

TitleDatePubMed
Epidermal growth factor-urogastrone: biological activity and receptor binding of derivatives.
1980-05
Patents

Patents

DE2415101
1
Name Type Language
MURODERMIN
INN   WHO-DD  
INN  
Official Name English
murodermin [INN]
Preferred Name English
.ALPHA.-EPIDERMAL GROWTH FACTOR (MOUSE SALIVARY GLAND REDUCED), CYCLIC (6->20),(14->31),(33->42)-TRIS(DISULFIDE)
Common Name English
MURINE EPIDERMAL GROWTH FACTOR
Common Name English
Murodermin [WHO-DD]
Common Name English
ALPHA-EPIDERMAL GROWTH FACTOR (MOUSE SALIVARY GLAND)
Common Name English
Code System Code Type Description
WIKIPEDIA
Murodermin
Created by admin on Wed Apr 02 09:06:12 GMT 2025 , Edited by admin on Wed Apr 02 09:06:12 GMT 2025
PRIMARY
CAS
54017-73-1
Created by admin on Wed Apr 02 09:06:12 GMT 2025 , Edited by admin on Wed Apr 02 09:06:12 GMT 2025
PRIMARY
SMS_ID
300000025187
Created by admin on Wed Apr 02 09:06:12 GMT 2025 , Edited by admin on Wed Apr 02 09:06:12 GMT 2025
PRIMARY
FDA UNII
7B6TM0214A
Created by admin on Wed Apr 02 09:06:12 GMT 2025 , Edited by admin on Wed Apr 02 09:06:12 GMT 2025
PRIMARY
EPA CompTox
DTXSID40202364
Created by admin on Wed Apr 02 09:06:12 GMT 2025 , Edited by admin on Wed Apr 02 09:06:12 GMT 2025
PRIMARY
ChEMBL
CHEMBL2109202
Created by admin on Wed Apr 02 09:06:12 GMT 2025 , Edited by admin on Wed Apr 02 09:06:12 GMT 2025
PRIMARY
INN
6251
Created by admin on Wed Apr 02 09:06:12 GMT 2025 , Edited by admin on Wed Apr 02 09:06:12 GMT 2025
PRIMARY
NCI_THESAURUS
C167014
Created by admin on Wed Apr 02 09:06:12 GMT 2025 , Edited by admin on Wed Apr 02 09:06:12 GMT 2025
PRIMARY
ACTIVE MOIETY
MURODERMIN
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966